23-May-2024
No headlines found.
Novanta Announces Financial Results for the First Quarter 2024
Business Wire (Tue, 7-May 6:59 AM ET)
Business Wire (Wed, 1-May 5:00 PM ET)
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
Business Wire (Fri, 19-Apr 3:48 PM ET)
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 7, 2024
Business Wire (Tue, 9-Apr 5:00 PM ET)
Politan Nominates Two Independent Candidates for Masimo Board
Business Wire (Mon, 25-Mar 7:00 AM ET)
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2023
Business Wire (Wed, 28-Feb 6:59 AM ET)
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Novanta - Common Shares trades on the NASDAQ stock market under the symbol NOVT.
As of May 23, 2024, NOVT stock price declined to $162.36 with 95,857 million shares trading.
NOVT has a beta of 2.22, meaning it tends to be more sensitive to market movements. NOVT has a correlation of 0.46 to the broad based SPY ETF.
NOVT has a market cap of $5.83 billion. This is considered a Mid Cap stock.
Last quarter Novanta - Common Shares reported $231 million in Revenue and $.74 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.16.
In the last 3 years, NOVT stock traded as high as $187.61 and as low as $110.84.
The top ETF exchange traded funds that NOVT belongs to (by Net Assets): IJH, VTI, VB, IWM, VXF.
NOVT has underperformed the market in the last year with a price return of -0.1% while the SPY ETF gained +28.6%. NOVT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.4% and +0.4%, respectively, while the SPY returned +3.9% and +1.1%, respectively.
NOVT support price is $161.24 and resistance is $168.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NOVT stock will trade within this expected range on the day.